Clinical Trial Update: Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous tranexamic acid to reduce blood loss in hip fracture patients with anemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hip Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Alejandro Lizaur-Utrilla, PhD, MD | Conditions: Hip Fractures, Anemia | Phase 4 | Status: COMPLETED